Home - Products - Others - Other Targets - Cyanidin3-xylosyl-(coumaroyl-glucosyl)-galactoside

Cyanidin3-xylosyl-(coumaroyl-glucosyl)-galactoside

CAS No. 142506-21-6

Cyanidin3-xylosyl-(coumaroyl-glucosyl)-galactoside( ——— )

Catalog No. M39728 CAS No. 142506-21-6

Cyanidin3-xylosyl-(coumaroyl-glucosyl)-galactoside

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cyanidin3-xylosyl-(coumaroyl-glucosyl)-galactoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Cyanidin3-xylosyl-(coumaroyl-glucosyl)-galactoside
  • Description
    Cyanidin3-xylosyl-(coumaroyl-glucosyl)-galactoside
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    142506-21-6
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Zingerone

    Zingerone

  • (R)-Nepicastat HCl

    (R)-Nepicastat HCl, the R-enantiomer of Nepicastat HCl, is a potent and selective inhibitor with IC50 of 25.1 nM and 18.3 nM for bovine and human dopamine-β-hydroxylase, with negligible affinity for twelve other enzymes and thirteen neurotransmitter receptors.

  • (Asp76)-pTH (39-84) ...

    (Asp76)-pTH (39-84) (human) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.